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For the reader who believes that
only computers can faithfully
duplicate gigabits of information,
some insights into his or her own
biology will be revealing. Just as he
or she reads this Primer, billions of
his or her cells prepare for division
by replicating the six billion or so
DNA nucleotides of their diploid
genomes, each cell typically making
not more than a single mistake. This
extraordinary precision is critical for
maintaining the health of an
organism, as a persisting
misincorporated nucleotide results in
a mutation when copied during the
next round of replication. If present
in a growth-controlling gene, this
mutation might trigger the cellular
derailment that underlies the
development of cancer. Avoiding
persistent misincorporations is
crucial not only in somatic cells, but
also in germ-line cells, where
mutations may introduce hereditary
defects into the species.
So what are the cellular tools that
push replicational mutagenesis down
to its almost unimaginably low rate?
This cellular machinery acts at three
stages. First comes the rigorous
nucleotide selectivity of the
replicative DNA polymerases,
followed secondly by the removal of
most inadvertent incorporations by
the proofreading functions
associated with the polymerases.
The resulting misincorporation rate
of 10–7 per duplicated nucleotide
would already seem to be an
unprecedented accuracy for any
enzyme. However, the ensuing rate
of mutagenesis would still be far too
high to keep the genome in shape.
To further eliminate
misincorporations, DNA mismatch
repair is called into action. This last
stage of defense against replication-
associated mutations entered the
spotlight in 1993, when inherited
defects in mismatch repair were
associated with a cancer
predisposition syndrome called
hereditary nonpolyposis colorectal
cancer. In addition, a number of
sporadic cancers have also been
associated with defects in mismatch
repair.
DNA mismatch repair has been
studied in bacteria for over two
decades, so prokaryotes have
provided a paradigm to guide
research in yeast, plants and
mammals. Molecular and
mechanistic insights into mismatch
repair have emerged from studies by
geneticists, cell biologists,
biochemists and X-ray
crystallographers. These studies have
not only revealed that mismatch
repair removes up to 99.9% of
mismatches resulting from
polymerase errors, but have also
uncovered roles for mismatch repair
proteins in diverse, seemingly
unrelated, DNA-associated metabolic
processes.
Phases of mismatch repair
In efficiently carrying out its error
correction, mismatch repair
successfully meets a number of
challenges. First, it recognizes a wide
Figure 1
A pair of praying hands holding mismatched
DNA (left) is a useful image of the crystal
structure of the E. coli MutS dimer (right).
The MutS structure is shown slightly rotated
around its vertical axis. Only the right
monomer is involved in mismatch
recognition. The clamp (‘fingertip’, orange)
holds on to the DNA backbone and is
connected, via the lever (‘finger’, red) to the
core domain (posterior of the ‘hand palm’,
brown). The connector domain (anterior of
the ‘hand palm’, blue) connects the core
domain with the mismatch-binding domain
(‘thumb’, purple). The ATPase domain (‘wrist’,
green) of only the mismatch-binding
monomer contains bound ADP (brown). The
helix–turn–helix domain (light brown) is
involved in dimerization and lies at the
bottom of the molecule. The 58 carboxy-
terminal amino acids, probably involved in
multimerization (but not in mismatch
binding), are not present in the protein
structure. The DNA (dark brown) is kinked
60° by MutS binding, resulting in minor
groove widening. A phenylalanine-containing
loop from the mismatch-binding domain
inserts between the G–T mismatched
nucleotides (yellow).
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spectrum of rare mismatches,
embedded in millions of correctly
base-pairing nucleotides. Second,
mismatch repair unequivocally
discriminates between a correct
nucleotide in the template strand and
a perfectly normal, but incorrect,
nucleotide in the newly replicated
DNA so as to prevent rather than fix
mutations. Next, mismatch repair
removes a patch of nascent DNA,
including the misincorporated
nucleotide, terminating excision just
beyond the mismatch. Finally,
mismatch repair fills the excision gap
by high-fidelity DNA synthesis;
ligation subsequently restores strand
continuity.
Mismatch recognition and binding
Genetic analysis of Escherichia coli
strains displaying highly increased
spontaneous mutation rates
identified the mutS, mutL, mutH and
mutU mismatch repair loci.
Reconstitution of mismatch repair
in vitro has unveiled the function of
the unique repair proteins MutS,
MutL and MutH, and has identified
a number of other gene products
and nucleotide cofactors involved in
the process. Central to the pathway
is MutS, a dimeric protein that binds
to mismatched DNA and displays an
intrinsic ATPase activity. T–G and
C–A mismatches, resulting in
transition mutations when allowed
to persist, are bound and repaired
more efficiently than other
mismatches; the transversion
mismatch C–C is the only mispair
refractory to repair. In addition,
unpaired nucleotides resulting from
insertions and deletions of a few
nucleotides, called
insertion/deletion loops, are
recognized by MutS and repaired by
mismatch repair. These in vitro
studies correlate well with the
in vivo mutation spectra of mutS, L,
H or U strains.
Recent descriptions of three-
dimensional MutS structures have
shed light on the mechanism of
binding of the protein to
mismatches. To visualize the MutS
dimer, a pair of praying hands is a
useful image (Figure 1). The
structurally and functionally
asymmetric MutS monomers each
consist of seven discernible domains.
The clamps, or ‘fingertips’, that
embrace the DNA helix connect to
the core domains, or ‘posterior
palms’, via the levers, or ‘fingers’,
which are opened in the absence of
DNA. The mismatch-binding
domain, or ‘thumb’, of only the right
monomer, which is connected via the
connector domain, or ‘anterior palm’,
to the core domain, inserts a bulky
phenylalanine residue into the
widened minor groove at the site of
the mispair. As a result of MutS
binding, the DNA helix is kinked
60° at the site of the mismatch,
suggesting that MutS tests the DNA
for increased flexibility caused by
disrupted basepairing. This model is
Figure 2
Steps of mismatch repair in E. coli. (a) A
mispair, indicated by M, is recognized by a
MutS dimer (or possibly a tetramer, gray). 
(b) After ATP and MutL (green) binding, the
multimeric complex may search for a
hemimethylated GATC sequence (asterisk),
where MutH (orange) bound to MutL cleaves
at the unmethylated strand. The precise
mechanism of the search for a strand
discrimination signal remains elusive.
Subsequently MutL loads the MutU helicase
(pink), which is followed by unwinding the
helix towards the mismatch. (c) An
exonuclease (Exo, yellow) then degrades the
unwound DNA up to a site just beyond the
mismatch. (d) Finally, mismatch repair is
completed by DNA resynthesis using the
polymerase III holoenzyme (red) followed by






















in agreement with biochemical data
showing that the efficiency of repair
depends partially on the DNA
sequence context. At the base of the
protein dimer lie the intertwined
dimeric ATPase domains, the
‘wrists’. In the Escherichia coli MutS
structure the right, mismatch-
binding monomer binds ADP,
whereas the other monomer contains
no nucleotide. Binding of ATP
following mismatch binding,
induced by long-range signal
transduction within the dimer,
causes major protein structural
changes. In vitro, this results in
departure of MutS from the
mismatch while still embracing the
DNA (Figure 2). This is thought to
begin the search for a distant strand
discrimination signal. It is
controversial whether the
subsequent MutS movement
requires the hydrolysis of ATP or
whether ATP binding alone serves to
initiate the conformational change.
The MutL homodimer also binds
ATP and subsequently undergoes a
conformational change; this allows it
to bind the MutS–ATP mismatch
complex. Remarkably, this ATP-
bound ternary complex is not
released from the mismatch, but
remains associated with it. Thus,
ATP and MutL might serve to
impose additional stringency on
MutS–mismatch binding, improving
the signal-to-noise ratio for mismatch
repair.
So how can the search for a strand
discrimination signal now be
performed? The observed tendency
of MutS to tetramerize, via its
carboxy-terminal end, may provide a
clue. One MutS dimer within a
tetramer might be engaged, with
MutL and ATP, in flagging the
mismatch, whereas the free MutS
dimer within the tetramer might
assume the ATP-dependent sliding
conformation, pulling the adjacent
DNA through its upper cavity until a
strand discrimination signal is
detected. The advantage of such a
mechanism is clear: the flag at the
mismatch may direct termination of
mismatch-repair-dependent excision
just beyond the mismatch.
Alternatively, termination of the
excision step might be triggered by
loading of new MutS dimers, or
tetramers, to the mismatch, thus
signaling its location.
Downstream steps in mismatch repair
in E. coli
Although the role of MutL in aiding
mismatch recognition remains
elusive to some extent, its
involvement in subsequent mismatch
repair events is better understood. In
E. coli, strand discrimination exploits
the lag of adenosine methylation at
palindromic GATC sequences in the
newly synthesized strand. The new
strand is incised by the MutL-
dependent MutH endonuclease near
an unmethylated GATC sequence, in
the presence of ATP. Remarkably,
cleavage is efficient at GATC sites a
kilobase or more in either direction
from the mismatch. Next, the
MutS–MutL–ATP complex binds
MutU — also called helicase II or
UvrD — and aids its loading at the
incised GATC site; unwinding of the
helix then proceeds towards the
mismatch. The unwound
misincorporation-containing DNA
strand is degraded by any of a
number of single-strand specific
nucleases, from the strand
discontinuity to a few nucleotides
beyond the mismatch. Finally, the
replicative DNA polymerase III
holoenzyme resynthesizes the
excised stretch, after which ligase
restores strand continuity.
Mismatch repair in eukaryotes
Initial steps of mismatch repair have
been conserved during evolution.
The functional dichotomy found in
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Figure 3
Roles of mismatch repair in determining the
outcome of homologous DNA recombination.
Top: both ends of each strand of a broken,
gapped, DNA molecule (gray backbone) form
a heteroduplex junction with a homologous
DNA molecule (orange backbone), each
consisting of two heteroduplex joints. Note
that this represents a simplification of the
Holliday model. Sequence divergences
between the recombining molecules are
apparent as mismatches (M). Mismatch repair
proteins can determine the outcome of
recombination in three ways: (a) crossover,
resulting in an exchange of flanking DNA.
This generally is accompanied by repair of the
mismatch (‘gene conversion’, indicated by
CM). (b) Gene conversion without crossover.
(c) Anti-recombination by mismatch repair
proteins in somatic cells results in reversion
of mismatch-containing heteroduplexes.
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the E. coli MutS dimers has led to
genetic divergence in eukaryotes.
The principal MutS homologue,
MSH, is a heterodimer of the MSH2
and MSH6 proteins and repairs
base–base mismatches and short
insertion/deletion loops. A dimer of
MSH2 and MSH3 mainly repairs
larger insertion/deletion loops. In
these heterodimers, MSH6 or MSH3
provide the mismatch recognition,
MSH2 functioning similarly to the
left monomer in the MutS dimer.
The major MutL-homologous dimer




steps in eukaryotic mismatch repair,
such as the identity of the helicases
and exonucleases, are poorly
understood. In vitro, a discontinuity
in one of the DNA strands suffices to
confer strand specificity to mismatch
repair. Recently PCNA, the trimeric
DNA-polymerase-associated DNA
clamp, has been shown to interact
with MSH3 or MSH6 and to be
required for mismatch repair. The
fixed orientation of PCNA with
respect of the replication fork might
therefore confer strand
discrimination to mismatch repair
in vivo. 
Other roles for mismatch repair
proteins
Over the past years additional
functions have emerged for
mismatch repair proteins. The first
was the involvement of mismatch
repair proteins with homologous
DNA recombination, one of the
pathways that repair DNA double-
strand breaks. A key intermediate in
this repair process is heteroduplex
joint formation between the ends of
the broken molecule and an intact,
homologous partner (Figure 3).
During meiosis, the specialized
MutS-homologous dimer
MSH4–MSH5 stimulates the
induction of crossovers at joints
between homologous autosomes, in
conjunction with the MutL
homologues (Figure 3a).
Polymorphisms, commonly present
in homologous autosomes, are
apparent as mismatches within the
joints. MSH2–MSH6, together with
the MutL homologues, corrects these
mismatches in a process called gene
conversion (Figure 3a,b). Double
strand breaks in somatic cells, such as
those induced by X-rays, may result
in translocations or in loss of genetic
information when homologous
recombination takes place between
nonidentical sequences, such as
pseudogenes or homologous
autosomes, rather than between
identical sister chromatids. In these
cells, mismatch repair generally does
not perform gene conversion, but
instead antagonizes mismatch-
containing heteroduplex joints in a
process called anti-recombination
(Figure 3c). Absence of mismatch
repair, therefore, allows crossover
between diverged sequences. As an
example, crosses between E. coli and
mismatch-repair-deficient Salmonella
typhimurium cells result in
interspecies hybrids, because
crossovers between the 20% diverged
genomes now proceed unrestrained.
In mammalian cells, mismatch
repair is involved in triggering
apoptosis induced by certain DNA
damaging agents. The best examples
are agents that methylate the O6
position of guanosine residues,
including certain carcinostatic drugs.
Wild-type cells are extremely
sensitive to these drugs, as
incorporation of either C or T
opposite O6Me–G residues triggers
mismatch-repair-dependent excision.
However, resynthesis introduces the
same ‘mismatch’, resulting in futile
cycles of mismatch repair that
ultimately result in apoptosis. An
alternative explanation for the
mismatch repair dependence of the
toxicity of these agents is provided
by the similarity of MSH2–MSH6 to
Ras nucleotide exchange factors that
are active in a GTP-bound form and
inactive in a GDP-bound form.
MSH2–MSH6, binding to the
methylated mispair, exchanges ATP
for ADP and might directly signal to
downstream effectors of apoptosis.
Supporting this model is the
detection of mismatch repair proteins
in the so-called BRCA1-associated
genome surveillance complex,
implicated in signaling of DNA
damage to cell cycle regulators.
Mismatch repair proteins are
implicated in several other DNA
repair processes, including repair of
oxidative nucleotide damage in the
transcribed strand of genes, in repair
of DNA crosslinks, and in the
processing of DNA ends during the
single-strand annealing pathway of
double strand break repair. All these
seemingly diverse activities justify
the assignment to mismatch repair of
the honorary title ‘Caretaker of our
Genome’.
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